Related books on 'genotyping'
Return to life science book listNumber of products: 343
Page 5 of 35
|
by: Icon Group publisher: Icon Group International, published: 2008-09-20 ASIN: B001OM509E This econometric study covers the world outlook for genotyping analysis services across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for genotyping analysis services. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business. |
|
by: Icon Group International publisher: Icon Group International, published: 2009-01-05 ASIN: B001POX3GS This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market. In performing various economic analyses for its clients, I have been occasionally asked to investigate the market potential for various products and services across cities. The purpose of the studies is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another. In what follows, I summarize the economic potential for the world's major cities for "genotyping analysis services" for the year 2009. The goal of this report is to report my findings on the real economic potential, or what an economist calls the latent demand, represented by a city when defined as an area of dominant influence. The reader needs to realize that latent demand may or may not represent real sales. |
|
by: Bruce Jancin publisher: International Medical News Group, published: 2009-01-01 ASIN: B001S6O2AY This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2009. The length of the article is 796 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Genotyping reveals CHD risk in type 2 group.(CARDIOVASCULAR MEDICINE)(coronary heart disease) Author: Bruce Jancin Publication: Family Practice News (Magazine/Journal) Date: January 1, 2009 Publisher: International Medical News Group Volume: 39 Issue: 1 Page: 9(1) Distributed by Gale, a part of Cengage Learning |
|
|
by: C. Kamatchi publisher: Science Publications, published: 2009-04-01 ASIN: B002QE1H32 This digital document is an article from American Journal of Infectious Diseases, published by Science Publications on April 1, 2009. The length of the article is 5472 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. From the author: Key words: Klebsiella pneumoniae, ESBL, TEM, SHV, CTX-M, multi-drug resistant, Hemidesmus indicus, Terminalia arjuna Citation Details Title: Identification of clonal clusters of Klebsiella pneumoniae isolates from Chennai by extended spectrum beta lactamase genotyping and antibiotic resistance phenotyping analysis.(Report) Author: C. Kamatchi Publication: American Journal of Infectious Diseases (Magazine/Journal) Date: April 1, 2009 Publisher: Science Publications Volume: 5 Issue: 2 Page: 74(9) Article Type: Report Distributed by Gale, a part of Cengage Learning |
|
|
by: Mitchel L. Zoler publisher: International Medical News Group, published: 2010-04-15 ASIN: B003P4BAXY This digital document is an article from Family Practice News, published by International Medical News Group on April 15, 2010. The length of the article is 494 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Genotyping for Warfarin sensitivity may cut hospitalization.(CARDIOVASCULAR MEDICINE)(Report) Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: April 15, 2010 Publisher: International Medical News Group Volume: 40 Issue: 7 Page: 13(1) Article Type: Report Distributed by Gale, a part of Cengage Learning |
|
|
by: Mary Ann Moon publisher: International Medical News Group, published: 2011-04-15 ASIN: B0052B9K62 This digital document is an article from Internal Medicine News, published by International Medical News Group on April 15, 2011. The length of the article is 630 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Consider genotyping before carbamazepine use.(NEUROLOGY) Author: Mary Ann Moon Publication: Internal Medicine News (Magazine/Journal) Date: April 15, 2011 Publisher: International Medical News Group Volume: 44 Issue: 7 Page: 16(1) Distributed by Gale, a part of Cengage Learning |
|
|
by: Mitchel L. Zolera publisher: International Medical News Group, published: 2011-09-01 ASIN: B005RISHSM This digital document is an article from Skin & Allergy News, published by International Medical News Group on September 1, 2011. The length of the article is 1177 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Vemurafenib approval opens melanoma genotyping floodgate.(News) Author: Mitchel L. Zolera Publication: Skin & Allergy News (Magazine/Journal) Date: September 1, 2011 Publisher: International Medical News Group Volume: 42 Issue: 9 Page: 1(2) Distributed by Gale, a part of Cengage Learning |
|
|
by: Centers for Disease Control and Prevention published: 2011-12-07 ASIN: B006JPDAN4 This guide provides an introduction to the application of tuberculosis (TB) genotyping to TB control practices and to the Centers for Disease Control and Prevention (CDC) TB Genotyping Program. It was written by the National Tuberculosis Controllers Association (NTCA)/CDC Advisory Group on Tuberculosis Genotyping and is intended for TB controllers, epidemiologists, laboratorians, and other program staff members who will be involved in submitting isolates for genotyping, analyzing and responding to genotyping results, or using genotyping data to monitor TB transmission trends. This guide does not contain specific directions on how a TB control program must carry out its genotyping program. The CDC genotyping program is not a research effort, and participating state and local programs are not required to carry out a protocol, submit a certain number of isolates, or collect specific data. Rather, this guide provides general guidance about how to utilize the genotyping laboratories, how to understand genotyping results, and how to apply those results to improve TB control practices. |
|
by: Linda Xiao publisher: American Water Works Research Foundation, published: 2006-08-03 ASIN: 1583214410 EAN: 9781583214411 sales rank: 11125558 Waterborne cryptosporidiosis presents a serious threat to human health due to the ubiquitous distribution of Cryptosporidium spp. in humans, animals and water, and resistance of the oocysts to harsh environmental condition, various disinfectants and many treatment practices. This report discusses the use of genotyping tools in the analysis of Cryptosporidium oocysts in water samples, including the interpretation of molecular data generated, and the development of quality control and quality assurance procedures.CD included with Appendices. |
|
publisher: Wiley, published: 2012-03-27 ASIN: 047043354X EAN: 9780470433546 sales rank: 2950381 The one-stop reference to pharmacogenetics and its impact on pharmaceuticals, therapeutics, and clinical practices Pharmacogenetics and Individualized Therapy offers thorough coverage of the study of the genetic determinants of drug response at the single gene level—and its impact on pharmaceuticals, therapeutics, and clinical practice. Providing an overview of the molecular basis of pharmacogenetics, the book helps readers understand the implications of genetic variability on pharmacokinetics and pharmacodynamics, as well as other aspects such as adverse drug reactions. Providing coverage of specific disease areas, including cardiovascular concerns, cancer and asthma/COPD, transplantation, and pain medication, the book also looks at the clinical practices, along with the psychiatric and ethical issues that have come to dominate conversation about pharmacogenetics. The technological applications of pharmacogenetics, including genotyping, drug disposition (metabolism and enzymes), and the impact of this research on the pharmaceutical industry and regulatory matters are all addressed in chapters by internationally recognized leaders from both academia and industry. Including chapters on specific therapeutic areas and clinical aspects, Pharmacogenetics and Individualized Therapy helps readers, whether they're students or researchers, to understand the implications of genetic variability on pharmacokinetics and pharmacodynamics. |